NICHIBAN CO., LTD.
4218・Prime Market・Chemicals
NICHIBAN CO., LTD.4218
NICHIBAN CO., LTD.4218
Reference Indicators
Market Cap
397¥100M
P/E (Forecast)
—
P/B
0.9x
Dividend Yield (Forecast)
2.09%
ROE
3.8%
EV/EBITDA
5.5x
Financial Summary
Unit: ¥M
| Item | 2022Mar 2022 | 2023Mar 2023 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 |
|---|---|---|---|---|---|
Net Sales | 43,134 | 45,560 | 46,859 | 49,457 | 50,470 |
Cost of Sales | 29,638 | 32,586 | 32,988 | 34,555 | 35,445 |
Gross Profit | 13,496 | 12,974 | 13,871 | 14,902 | 15,025 |
SG&A Expenses | 11,046 | 11,365 | 11,798 | 12,315 | 12,754 |
Operating Income | 2,450 | 1,609 | 2,073 | 2,586 | 2,270 |
Non-operating Income | 236 | 284 | 303 | 339 | 338 |
Non-operating Expenses | 124 | 145 | 175 | 244 | 166 |
Ordinary Income | 2,561 | 1,748 | 2,201 | 2,681 | 2,442 |
Extraordinary Income | — | 1,683 | 71 | — | — |
Extraordinary Losses | — | — | — | 53 | 317 |
Pre-tax Income | 2,561 | 3,431 | 2,273 | 2,628 | 2,125 |
Income Taxes | 751 | 1,059 | 445 | 668 | 472 |
Net Income | 1,809 | 2,371 | 1,827 | 1,959 | 1,652 |
EBITDA | 4,995 | 4,366 | 4,868 | 5,731 | 5,113 |
Gross Margin | 31.3% | 28.5% | 29.6% | 30.1% | 29.8% |
Operating Margin | 5.7% | 3.5% | 4.4% | 5.2% | 4.5% |
ROA | 2.8% | 3.4% | 2.7% | 2.9% | 2.5% |
ROE | 4.7% | 6.0% | 4.4% | 4.6% | 3.8% |
Segment Performance
Unit: ¥M
2026
| Segment | Net Sales | Operating Income | Operating Margin |
|---|---|---|---|
| メディカル事業 | 24,936 | 6,325 | 25.4% |
| テープ事業 | 25,534 | 828 | 3.2% |